好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

The importance of intra-operative assessment in VIM DBS for Tremor: Insights from 145 procedures
Movement Disorders
P4 - Poster Session 4 (5:30 PM-6:30 PM)
10-030

To evaluate the importance of intraoperative assessment in deep brain stimulation (DBS) of the ventral intermediate (Vim) nucleus of the thalamus.

Vim DBS is a well-established modality for treatment of tremor. It reduces the amplitude and decreases the regularity of tremor. The procedure is traditionally performed without general anesthesia, based on coordinates derived from stereotactic anatomic atlases, with the option of electrode repositioning based on intraoperative testing. Recent literature suggests equivalence in effectiveness and safety in procedures done with (with the patient asleep) and without general anesthesia (with the patient awake).

We retrospectively reviewed intraoperative documentation in Vim DBS procedures from 2004 to 2018 at the University of Cincinnati. All procedures were performed under local anesthesia.  Data on encounters in which electrode repositioning was needed to a) prevent stimulation-induced side effects, and/ or b) optimize efficacy was reviewed. Change in parallel trajectory was classified as major repositioning, whereas change in depth of electrode was classified as minor repositioning.

Vim DBS was performed in 124 patients with essential tremor, 11 with dystonic tremor, 2 with Parkinson’s disease, 4 with other forms of tremor.  A total of 145 encounters (each unilateral lead placement counted as one encounter) were reviewed, out of which 60.7% (88 encounters) involved repositioning of the electrode: 49 encounters involved minor repositioning, 10 required major repositioning and 29 involved both.  The reason for repositioning was identified as efficacy in 34 encounters, side effects in 26 encounters and both in 28 encounters. During these 88 encounters, the electrode was re-positioned a total of 207 times. In the 95 alterations done to ameliorate side effects, 34 lead to complete resolution and 28 showed partial improvement.

Electrode repositioning was required for the majority of Vim DBS cases for optimal tremor control and reduction of side effects, demonstrating the importance of intraoperative assessment.

Authors/Disclosures
Abhimanyu Mahajan, MD, MHS, FAAN (University of Cincinnati)
PRESENTER
Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vima Therapeutics, Inc.. Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AskBio. Dr. Mahajan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie . Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aspen Neuroscience. Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Adaptive Biosciences . Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AskBio. Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement disorders clinical practice. Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with Texas Alzheimer's Research And Care Consortium .
Alexander J. Bader, MD (University of Illinois at Chicago) No disclosure on file
Andrew P. Duker, MD (University of Cincinnati) No disclosure on file
Alberto J. Espay, MD, FAAN (University of Cincinnati) Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Tanabe Pharma America (formerly, Neuroderm). Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acorda. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Herantis Pharma. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus (formerly USWorldMeds). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaps Dx. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bial. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NeuroDiagnostics, Inc (SYNAPS Dx). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Intrance Medical Systems, Inc.. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Praxis Precision Medicines. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Citrus Health. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AskBio. The institution of Dr. Espay has received research support from NIH. The institution of Dr. Espay has received research support from Michael J Fox Foundation for Parkinson's Research. Dr. Espay has received intellectual property interests from a discovery or technology relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care.
Cara Jacob, MD (University of Cincinnati) No disclosure on file
Aristide Merola, MD, PhD (The Ohio State University) Dr. Merola has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Merola has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbott. Dr. Merola has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology.
No disclosure on file